Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
WASHINGTON, D.C. The Food and Drug Administration has asked AstraZeneca to “immediately cease the dissemination” of an ad touting the safety of its cholesterol drug Crestor, calling the claims misleading.
Client representative Emily Denney said the execution was intended only to run for a short time and the FDA has been advised that it is no longer being used.
Quantum in Parsippany, N.J., a unit of WPP Group’s CommonHealth, has been lead agency for Crestor, which competes with such brands as Pfizer’s Lipitor and Merck’s Zocor.
“The
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in